Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc. (VYGR), sold 12,192 shares at $3.78 ($46K) on 2026-02-10, disclosed to the SEC on 2026-02-11.
Seasonal sale ($46k) by President and CEO — this insider has traded VYGR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $50K | — | Filing → |